Inventor
ZAPF CHRISTOPH WOLFGANG
US16 patents
⚠️ This page may combine multiple inventors who share the name “ZAPF CHRISTOPH WOLFGANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
10 patentsUS9879022B2Jan 30, 2018
Bicyclic-fused heteroaryl or aryl compounds
PFIZER19 citations93
US9458168B2Oct 4, 2016
Bicyclic-fused heteroaryl or aryl compounds
PFIZER17 citations92
US11702424B2Jul 18, 2023
Bicyclic-fused heteroaryl or aryl compounds
PFIZER4 citations85
US10793579B2Oct 6, 2020
Bicyclic-fused heteroaryl or aryl compounds
PFIZER3 citations83
US10329302B2Jun 25, 2019
Bicyclic-fused heteroaryl or aryl compounds
PFIZER3 citations83
US10316018B2Jun 11, 2019
Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators
PFIZER2 citations72
US10174000B2Jan 8, 2019
Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators
PFIZER5 citations72
US10266513B2Apr 23, 2019
Bruton's tyrosine kinase inhibitors
PFIZER2 citations70
US12202836B2Jan 21, 2025
Bicyclic-fused heteroaryl or aryl compounds
PFIZER0 citations62
US10815213B2Oct 27, 2020
Bruton's tyrosine kinase inhibitors
PFIZER0 citations49
CYSTIC FIBROSIS FOUND THERAPEUTICS INC
4 patentsUS10208053B2Feb 19, 2019
Bicyclic heteroaryl derivatives as CFTR potentiators
CYSTIC FIBROSIS FOUND THERAPEUTICS INC31 citations92
US10131670B2Nov 20, 2018
Bicyclic heteroaryl derivatives as CFTR potentiators
CYSTIC FIBROSIS FOUND THERAPEUTICS INC27 citations92
US10377762B2Aug 13, 2019
Bicyclic heteroaryl derivatives as CFTR potentiators
CYSTIC FIBROSIS FOUND THERAPEUTICS INC1 citations71
US10301315B2May 28, 2019
Pyrrolopyrimidines as CFTR potentiators
CYSTIC FIBROSIS FOUND THERAPEUTICS INC1 citations61